Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Host immune responses to a viral immune modulating protein: immunogenicity of viral interleukin-10 in rhesus cytomegalovirus-infected rhesus macaques.

Eberhardt MK, Chang WL, Logsdon NJ, Yue Y, Walter MR, Barry PA.

PLoS One. 2012;7(5):e37931. doi: 10.1371/journal.pone.0037931. Epub 2012 May 24.

2.

Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus.

Logsdon NJ, Eberhardt MK, Allen CE, Barry PA, Walter MR.

PLoS One. 2011;6(11):e28127. doi: 10.1371/journal.pone.0028127. Epub 2011 Nov 21.

3.

Exploitation of Interleukin-10 (IL-10) Signaling Pathways: Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection.

Eberhardt MK, Deshpande A, Fike J, Short R, Schmidt KA, Blozis SA, Walter MR, Barry PA.

J Virol. 2016 Oct 14;90(21):9920-9930. Print 2016 Nov 1.

4.

Vaccination against a virus-encoded cytokine significantly restricts viral challenge.

Eberhardt MK, Deshpande A, Chang WL, Barthold SW, Walter MR, Barry PA.

J Virol. 2013 Nov;87(21):11323-31. doi: 10.1128/JVI.01925-13. Epub 2013 Aug 14.

5.

Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity.

Chang WL, Barry PA.

Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22647-52. doi: 10.1073/pnas.1013794108. Epub 2010 Dec 13.

6.

Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques.

Yue Y, Kaur A, Eberhardt MK, Kassis N, Zhou SS, Tarantal AF, Barry PA.

J Virol. 2007 Feb;81(3):1095-109. Epub 2006 Nov 15.

7.

Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques.

Yue Y, Zhou SS, Barry PA.

J Gen Virol. 2003 Dec;84(Pt 12):3371-9.

PMID:
14645918
8.

Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.

Ha S, Li F, Troutman MC, Freed DC, Tang A, Loughney JW, Wang D, Wang IM, Vlasak J, Nickle DC, Rustandi RR, Hamm M, DePhillips PA, Zhang N, McLellan JS, Zhu H, Adler SP, McVoy MA, An Z, Fu TM.

J Virol. 2017 Mar 13;91(7). pii: e02033-16. doi: 10.1128/JVI.02033-16. Print 2017 Apr 1.

10.

Limited dissemination and shedding of the UL128 complex-intact, UL/b'-defective rhesus cytomegalovirus strain 180.92.

Assaf BT, Mansfield KG, Strelow L, Westmoreland SV, Barry PA, Kaur A.

J Virol. 2014 Aug;88(16):9310-20. doi: 10.1128/JVI.00162-14. Epub 2014 Jun 4.

11.

Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis.

Sequar G, Britt WJ, Lakeman FD, Lockridge KM, Tarara RP, Canfield DR, Zhou SS, Gardner MB, Barry PA.

J Virol. 2002 Aug;76(15):7661-71.

12.

Antibodies to human IL-10 neutralize ebvIL-10-mediated cytokine suppression but have no effect on cmvIL-10 activity.

Brodeur ND, Spencer JV.

Virus Res. 2010 Nov;153(2):265-8. doi: 10.1016/j.virusres.2010.08.012. Epub 2010 Aug 20.

13.

Pathogenesis of experimental rhesus cytomegalovirus infection.

Lockridge KM, Sequar G, Zhou SS, Yue Y, Mandell CP, Barry PA.

J Virol. 1999 Nov;73(11):9576-83.

14.

Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood.

Young VP, Mariano MC, Tu CC, Allaire KM, Avdic S, Slobedman B, Spencer JV.

J Infect Dis. 2017 Mar 15;215(6):874-882. doi: 10.1093/infdis/jix043.

PMID:
28453840
15.

A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.

Wussow F, Yue Y, Martinez J, Deere JD, Longmate J, Herrmann A, Barry PA, Diamond DJ.

J Virol. 2013 Feb;87(3):1322-32. doi: 10.1128/JVI.01669-12. Epub 2012 Nov 14.

16.

Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques.

Yue Y, Wang Z, Abel K, Li J, Strelow L, Mandarino A, Eberhardt MK, Schmidt KA, Diamond DJ, Barry PA.

Med Microbiol Immunol. 2008 Jun;197(2):117-23. doi: 10.1007/s00430-008-0074-5. Epub 2008 Jan 15.

PMID:
18196272
17.

Rhesus and human cytomegalovirus glycoprotein L are required for infection and cell-to-cell spread of virus but cannot complement each other.

Bowman JJ, Lacayo JC, Burbelo P, Fischer ER, Cohen JI.

J Virol. 2011 Mar;85(5):2089-99. doi: 10.1128/JVI.01970-10. Epub 2010 Dec 29.

18.

Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus.

Yue Y, Barry PA.

Adv Virus Res. 2008;72:207-26. doi: 10.1016/S0065-3527(08)00405-3. Review.

PMID:
19081492
19.

Use of specific-pathogen-free (SPF) rhesus macaques to better model oral pediatric cytomegalovirus infection.

dela Pena MG, Strelow L, Barry PA, Abel K.

J Med Primatol. 2012 Jun;41(3):225-9. doi: 10.1111/j.1600-0684.2012.00541.x.

20.

Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques.

Abel K, Martinez J, Yue Y, Lacey SF, Wang Z, Strelow L, Dasgupta A, Li Z, Schmidt KA, Oxford KL, Assaf B, Longmate JA, Diamond DJ, Barry PA.

J Virol. 2011 Mar;85(6):2878-90. doi: 10.1128/JVI.00883-10. Epub 2010 Dec 29.

Supplemental Content

Support Center